T0	Participants 32 67	people at high cardiovascular risk:
T1	Participants 110 130	people with diabetes
T2	Participants 277 300	nondiabetic population.
T3	Participants 482 561	9297 participants, including 3577 with diabetes and 1956 with microalbuminuria.
T4	Participants 577 660	restricted to 7674 participants with albuminuria data at baseline and at follow-up.
T5	Participants 1748 1783	nondiabetic and in diabetic people.